This document is about sodium chloride 0.9% 100 mL intravenous solution, which is manufactured by Baxter and Freeflex. The product is used for correcting hydration deficits and electrolyte imbalances.
This document is a Medication Safety Communication intended as a guide for health professionals in NSW public health organizations. It addresses a disruption in the supply of Baxter® and Freeflex® sodium chloride 0.9% 100 mL intravenous solutions due to manufacturing issues and increased demand, with an unclear estimated resolution date. The document advises facilities to continue ordering regular brands from their usual suppliers unless advised otherwise and to reserve existing stock for fluid-restricted patients.